Navigation Links
Pilot Testing Phase Ends; Expansion Of Sales Force Begins

PreEmptive Meds, Inc., a plant-based pharma-nutraceutical company, which promotes its proprietary, all-natural formulations as evidence-based alternatives for the primary care physician, announces the completion of its pilot testing phase and its initiation of sales force expansion.

Whitehouse Station, NJ/Las Vegas, NV (PRWEB) April 14, 2010 -- PreEmptive Meds, Inc., a plant-based pharma-nutraceutical company, which promotes its proprietary, all-natural formulations as evidence-based alternatives for the primary care physician, announces the completion of its pilot testing phase and its initiation of sales force expansion.

Over the past three years, the company has been promoting, on a pilot test basis, its current product line with experienced pharmaceutical-trained sales associates to physicians in selected pockets of northern New Jersey, New York City and Long Island, NY with favorable acceptance and patient outcomes. The Company has now expanded its sales effort to 16 sales associates and plans to continue its expansion to 30 sales associates by July 1st, 2010. The current sales effort is and will be focused up and down the east coast corridor from Massachusetts to Florida, and into Texas, Pennsylvania and Illinois. Expansion is planned to continue throughout 2011 with the goal to have a national sales effort within prominent high-density metropolitan Primary Care Physician areas across the country.

The Company currently promotes seven products: PreCrea® for pre-diabetes; PreLipid® and PreLipid Plus®, for lowering cholesterol naturally; PreMenora® and PreMenora®Plus, for relieving symptoms of perimenopause; and PreArthros™, and PreArthros™Plus for joint inflammation and pain, via a pharmaceutical style sales force. In addition, the Company has also developed a series of new formulations as viable all-natural alternatives for various chronic conditions, which it plans to launch over time once it has established a sufficient beachhead with its current product line with Primary Care Physicians.

Chuck Blitzer, the Company’s Chief Executive Officer stated, “We are extremely pleased with the results from our pilot testing program (which reached over 1,500 physicians and over 200,000 patient experiences) and now, our effort to formally begin building a national sales organization. Our sales associates are highly proven individuals from the pharmaceutical industry and average over 12 years of direct selling experience within the Primary Care Physician community, the largest physician audience in the country.

Our products are recommended by thousands of physicians as:

1) First-line therapy for pre-disease states, where no prescription drugs are approved,
2) An alternative for patients who are intolerant to prescription drugs or refuse to go onto a prescription drug, and
3) Additive therapy to a given prescription drug where the desired therapeutic effect of such drug has not been achieved and the physician is inclined not to increase dose.”

The Company’s financial position is sound and it hasn’t needed to raise capital since its last round of financing in 2008. It is debt free and believes it is on track to break-even by years’ end.

Dr. Joe Fenn, President and Chief Medical Officer stated “From our pilot program we learned how to promote our products effectively to Primary Care Physicians, and in every sales territory we now expand to we have doctors eager to hear our message and adopt our products as alternatives for their patients. We have also established the efficacy and safety of our products in tens of thousands of patients. ”

PreEmptive Meds, Inc., is a pre-disease focused, plant-based pharma-nutraceutical company promoting its proprietary branded products directly to the Primary Care Physician community.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. HealthEquity Partners with State of Utah to Launch Pilot of Utah Health Exchange
2. Howard Leights New Pilot Push-in Ear Plug Delivers Occupational Hearing Protection with Innovative, Hybrid Design
3. Acumen Fund Announces Ripple Effect Pilot Projects In Kenya To Identify Innovative Solutions To Water Challenges
4. Edifecs Testifies Before NCVHS Standards Subcommittee Regarding HIPAA 5010 and ICD-10 Testing
5. Doctors and Scientists Create New Society to Promote Non-Animal Toxicology Testing Methods
6. The Institute of Women's Health of North America to Offer Free Chlamydia Testing at All Affiliated Campuses – Dr. Abdul Rao
7. AXIOM Systems, Inc. Announces General Release of HIPAA 5010 Testing Solutions
8. ANY LAB TEST NOW North Dallas Lowers Diabetes Testing to $89
9. Refinement of glaucoma testing, treatment expected from US, United Kingdom study
10. Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification
11. Statement from American Water Works Association on the Environmental Working Group's report on Tap Water Quality Testing and Violations
Post Your Comments:
Related Image:
Pilot Testing Phase Ends; Expansion Of Sales Force Begins
(Date:11/25/2015)... ... November 25, 2015 , ... Dr. John Pierce, Medical Director ... about hair loss treatment with the Capillus272™ Pro laser therapy cap. FDA cleared for ... and fuller hair, without the need for surgery, prescription pills, or topical foams. ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... United States District Court of Connecticut on behalf of a home health care worker ... all current or former home health care workers employed by Humana, Inc., Humana at ...
(Date:11/25/2015)... ... November 25, 2015 , ... According to an ... is being more and more widely heralded as a breakthrough for performing hernia repairs. ... has over traditional laparoscopic surgery is that it can greatly reduce the pain that ...
(Date:11/25/2015)... ... November 25, 2015 , ... Dental professionals who would like to become ... invited to attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will ... , As the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio ...
(Date:11/25/2015)... ... November 25, 2015 , ... Wimbledon Health Partners, the ... Wimbledon Athletics Facebook page to educate the public, parents and school ... About 2,000 people under the age of 25 die from sudden cardiac arrest ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ( ... Cardiac Pacemaker Market Outlook to 2019 - Rise in Cardiac ... " report to their offering. ... Boston scientific and others. --> ... Medtronic, Biotronik, Boston scientific and others. ...
(Date:11/26/2015)... Research and Markets ( ) ... Future Horizons and Growth Strategies in the Japanese ... Segment Forecasts, Competitive Intelligence, Emerging Opportunities" report ... --> This new 247-page report ... drug monitoring market, including emerging tests, technologies, instrumentation, ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 ... has announced the addition of the  ... in the Global Cell Surface Testing ... Opportunities" report to their offering.  ... the addition of the  "2016 Future ...
Breaking Medicine Technology: